by James Rudge, PhD, Technical Director, Neoteryx | 6 min read
An article by Elisabeth Leere Øiestad et al at the University of Oslo and other related institutions, published in the December 2021 issue of Journal of Sustainable Chemistry and Pharmacy, …
Read Storyby James Rudge, PhD, Technical Director, Neoteryx | 6 min read
Finger-stick collection of capillary blood for dried sample analysis is a highly convenient and minimally invasive alternative to conventional phlebotomy. With the increased availability of remote specimen collection tools like …
Read Storyby James Rudge, PhD, Technical Director, Neoteryx | 6 min read
An article by David J Marshall and Brian G Keevil et al at Wythenshawe Hospital and Nottingham Hospital, UK that was published in the July 2020 issue of Annals of …
Read Storyby James Rudge, PhD, Technical Director, Neoteryx | 8 min read
An article published by Nils T. Vethe et al in the October 2019 issue of Therapeutic Drug Monitoring, reported on the successful validation of 10 µL Mitra® devices from 26-27 …
Read Storyby Neoteryx | 3 min read
The COVID-19 pandemic has created a shift in the way researchers collect specimen samples for scientific studies and clinical trials. The scientific community has found it increasingly difficult to recruit …
Read Storyby Neoteryx | 3 min read
A viral pandemic was something that scientists had long predicted, but when and how it would strike was not known. Scientists and researchers also did not know that it would …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.